Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Xeris Pharmaceuticals Inc (NQ: XERS ) 2.875 -0.005 (-0.17%) Streaming Delayed Price Updated: 9:42 AM EDT, Aug 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 39,796 Open 2.920 Bid (Size) 2.870 (4) Ask (Size) 2.880 (69) Prev. Close 2.880 Today's Range 2.875 - 2.920 52wk Range 1.460 - 3.260 Shares Outstanding 66,497,370 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Xeris to Participate in Upcoming Investor Conferences August 22, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire More Than $20M Bet On Precigen? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying August 14, 2024 Via Benzinga Performance YTD +26.93% +26.93% 1 Month +10.15% +10.15% 3 Month +49.74% +49.74% 6 Month -7.56% -7.56% 1 Year +26.65% +26.65% More News Read More Xeris Biopharma And 2 Other Penny Stocks Insiders Are Buying August 13, 2024 Via Benzinga XERS Stock Earnings: Xeris Biopharma Holdings Beats EPS, Beats Revenue for Q2 2024 August 08, 2024 Via InvestorPlace Xeris Biopharma Reports Second Quarter 2024 Financial Results August 08, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement With Beta Bionics May 06, 2024 Via ACCESSWIRE Xeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024 July 25, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris Biopharma Announces CEO Succession Plan July 08, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) July 03, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing’s Syndrome Patients at ENDO 2024 June 03, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire 12 Health Care Stocks Moving In Thursday's Intraday Session May 30, 2024 Via Benzinga Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121) May 30, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris to Participate in the Jefferies Global Healthcare Conference May 30, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Socket Mobile And 3 Other Stocks Under $3 Insiders Are Buying May 13, 2024 Via Benzinga XERS Stock Earnings: Xeris Biopharma Holdings Misses EPS, Misses Revenue for Q1 2024 May 09, 2024 Via InvestorPlace Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events May 09, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Why Are Xeris Biopharma Shares Moving Monday? May 06, 2024 Via Benzinga Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionics May 06, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024 May 02, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) April 03, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference April 02, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire XERS Stock Earnings: Xeris Biopharma Holdings Meets EPS, Beats Revenue for Q4 2023 March 06, 2024 Via InvestorPlace Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events March 06, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital March 06, 2024 From Xeris Biopharma Holdings, Inc. Via Business Wire Earnings Scheduled For March 6, 2024 March 06, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
